Recombinant Human Dynamin-like 120 kDa protein, mitochondrial (OPA1)

What is the molecular structure and function of OPA1?

OPA1 is a dynamin-related protein with a molecular weight of approximately 120 kDa. The protein contains an NH2-terminal GTPase domain followed by a conserved middle domain and a putative helical domain called the assembly domain . Like other dynamin family members, OPA1 has divergent segments that likely determine its specific functions.

Methodologically, OPA1's function can be studied through:

• Protein domain analysis: The GTPase domain is particularly critical, as mutations in this region (such as K38A) result in dominant-negative effects on mitochondrial morphology .

• Subcellular localization studies: OPA1 localizes to the inner mitochondrial membrane (IMM), where it regulates mitochondrial fusion and cristae structure.

• Functional assays: OPA1 is involved in mitochondrial fusion, oxidative phosphorylation, maintenance of mitochondrial DNA, and apoptosis regulation .

Unlike other dynamin family members that function in membrane traffic (like dynamin and yeast vacuolar protein sorting factor), OPA1 specifically regulates mitochondrial dynamics without affecting the morphology of other organelles or transport pathways .

What are the key OPA1 isoforms and how are they utilized in research?

The OPA1 gene consists of 31 exons that produce 8 mRNA isoforms through alternative splicing of exons 4, 4b, and 5b . When designing experiments with recombinant OPA1, researchers should consider:

Table 1: Comparison of Key OPA1 Isoforms Used in Research

Both isoforms have been successfully employed to restore mitochondrial morphology in OPA1 knockout cells, converting fragmented mitochondria back to tubular networks . Experimental evidence shows that cells transfected with either optimized OPA1 isoform 1 or 7 demonstrate tubular mitochondrial networks, indicating restoration of mitochondrial fusion .

Importantly, OPA1 mRNA isoforms show tissue-specific expression patterns, which should be considered when selecting isoforms for research in specific tissue contexts .

What methods are recommended for detecting and quantifying OPA1 expression?

Reliable detection and quantification of OPA1 expression is crucial for experimental reproducibility. Standard methodological approaches include:

• RNA quantification via RT-PCR:

  • Design primers targeting all 8 endogenous OPA1 mRNA isoforms (e.g., F 5′-AGTAGAGGTTGCTTGGGAGAC-3′ and R 5′-TGTCATCATGCTCTTTCCCT-3′)

  • For optimized recombinant constructs, use specific primers (e.g., F 5′-TACCCCAGACTGAGAGAGCT-3′ and R 5′-ACTTGGCTCAGGGAGATCAC-3′)

  • Employ β-actin as an endogenous control

  • Generate standard curves from plasmids with known copy numbers to obtain absolute quantification

• Protein detection via immunofluorescence:

  • Fix cells with 4% paraformaldehyde for 20 minutes at room temperature

  • Block with 5% Donkey Serum and 0.3% Triton in PBS for 2 hours

  • For tagged recombinant OPA1, use specific antibodies (e.g., Anti-6xHIS at 1:500 dilution)

  • Counterstain nuclei with DAPI (1:50,000 in PBS for 10 min)

• Stable cell line generation:

  • Clone OPA1 isoforms into expression vectors (e.g., pcDNA3.1)

  • Transfect target cells (such as OPA1-/- MEFs)

  • Select with appropriate antibiotics (e.g., 200 μg/ml G418)

  • Isolate single-cell colonies and verify expression

When analyzing OPA1 expression, researchers must consider both long (l-form) and short (s-form) variants, as both forms are required to fully restore wild-type mitochondrial physiology .

How do mutations in OPA1 affect mitochondrial function?

OPA1 mutations produce distinct effects on mitochondrial morphology and function that can be studied through various experimental approaches:

• Morphological analysis:

  • In cells expressing mutant OPA1 (particularly GTPase domain mutants), mitochondrial tubular projections retract into large perinuclear aggregates

  • By electron microscopy, these aggregates appear as clusters of tubules rather than a large mass of coalescing membrane

  • Visualization can be achieved using mitochondrial markers followed by fluorescence microscopy

• Quantitative assessment:

  • Cells can be grouped by mitochondrial phenotype (punctate or rescued)

  • OPA1 fluorescence levels correlate with mitochondrial morphology

  • Statistical analysis can be used to determine the relationship between OPA1 expression levels and mitochondrial phenotype

• Pathogenic effects:

  • Most mutations causing optic atrophy type 1 create premature stop signals, resulting in unstable, truncated proteins

  • These mutations lead to misshapen, disorganized mitochondria with reduced energy-producing capabilities

  • The most common mutation in Danish populations is a single nucleotide deletion (2826delT)

The clinical spectrum of OPA1 mutations extends beyond visual impairment, with up to 20% of mutation carriers developing extra-ocular neurological complications including sensorineural deafness, ataxia, myopathy, peripheral neuropathy, and progressive external ophthalmoplegia .

How do different OPA1 isoforms contribute to mitochondrial dynamics and function?

Understanding the specific contributions of OPA1 isoforms requires sophisticated experimental approaches:

Table 2: Functional Contributions of OPA1 Forms

Methodologically, researchers can investigate isoform-specific functions through:

• Isoform-specific rescue experiments:

  • Generate cellular models lacking endogenous OPA1 (e.g., OPA1-/- MEFs)

  • Introduce individual OPA1 isoforms through transfection

  • Assess restoration of mitochondrial morphology and function

• Processing and cleavage studies:

  • Analyze the generation of s-forms from l-forms by OMA1 and YME1L proteases

  • Investigate the balance between forms under different cellular conditions

  • Evaluate the impact of mutations on processing efficiency

Research has shown that expression of any of the eight isoforms can restore mtDNA levels, reorganize cristae, and improve electron transport chain function, but both l and s-forms are needed to fully restore wild-type mitochondrial physiology .

What are the optimal experimental designs for studying OPA1 in neurodegenerative disease models?

OPA1 mutations cause dominant optic atrophy (DOA) and can lead to multi-system neurological disease in DOA+ variants. When designing experiments to study OPA1 in neurodegenerative contexts:

• Model selection considerations:

  • Patient-derived cells carrying pathogenic OPA1 mutations

  • Transgenic animal models (e.g., Opa1 delTTAG/+ mouse model)

  • In vitro models with specific OPA1 mutations or knockdown

• Therapeutic intervention strategies:

  • AAV-delivered OPA1 (particularly isoform 1) has shown significant protection of retinal ganglion cells (RGCs) in Opa1 delTTAG/+ mice

  • OPA1 delivery has demonstrated benefit in laser-induced glaucoma models and chemical models of ocular mitochondrial uncoupling

  • Constitutively expressing OPA1 mice showed increased mitochondrial supercomplex formation and protection from reperfusion ischemia damage

• Phenotypic assessment:

  • Visual function testing

  • RGC survival quantification

  • Mitochondrial function analysis in neuronal populations

  • Assessment of other neurological symptoms in DOA+ variants

Recent studies have demonstrated that l-form OPA1 can alleviate acute ischemic stroke injury in rat brain, preventing neuronal cell loss . Additionally, AAV-delivered OPA1 isoform 1 has shown protection in multiple models of optic neuropathy, though improvements in visual acuity may not always reach statistical significance .

How can researchers reconcile contradictory data on OPA1 function across different experimental systems?

When encountering contradictory results regarding OPA1 function, consider these methodological approaches to reconcile discrepancies:

• Expression level assessment:

  • Cells exhibit distinct mitochondrial phenotypes based on OPA1 expression levels

  • Quantitative analysis shows that cells with punctate mitochondria have significantly different OPA1 expression compared to cells with rescued tubular networks

  • Establish dose-response relationships between OPA1 levels and functional outcomes

• Isoform and processing considerations:

  • Different studies may utilize different OPA1 isoforms

  • The processing of l-form to s-form may vary between experimental systems

  • The ratio between forms affects functional outcomes

• Model-specific factors:

  • Cell type and tissue origin influence OPA1 function

  • The presence of endogenous OPA1 may confound results

  • The metabolic state and energy demands of the experimental system

• Mutation-specific effects:

  • Different OPA1 mutations exhibit variable penetrance and expressivity

  • Multi-system neurological features affect approximately 20% of OPA1 mutation carriers

  • Missense mutations may carry increased risk for extra-ocular complications (odds ratio = 3.06, 95% CI = 1.44–6.49)

When comparing studies, carefully evaluate the experimental variables, including the specific mutations, expression systems, and phenotypic assessments used.

What methodological approaches are recommended for investigating OPA1's role in mitochondrial DNA maintenance?

OPA1 plays a critical role in maintaining mitochondrial DNA (mtDNA). To effectively study this function:

Table 3: Experimental Approaches for Studying OPA1's Role in mtDNA Maintenance

Research has demonstrated that expression of OPA1 isoforms can restore mtDNA levels in OPA1 knockout cells . To thoroughly investigate this function:

• Establish baseline measurements:

  • Determine mtDNA copy number in control and experimental conditions

  • Assess mtDNA integrity and nucleoid organization

  • Measure mitochondrial respiratory function

• Conduct rescue experiments:

  • Introduce wild-type or mutant OPA1 into deficient systems

  • Monitor changes in mtDNA parameters over time

  • Correlate mtDNA restoration with functional recovery

• Investigate mechanism:

  • Examine the relationship between mitochondrial fusion and mtDNA maintenance

  • Assess nucleoid organization in relation to cristae structure

  • Determine if l-form and s-form OPA1 have differential effects on mtDNA